Assessment of ADAMTS‐13 activity is now routinely performed in patients presenting with acute TMA and, when < 10%, aids in the differentiation of TTP from other causes of TMA 9, 10. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.